Scaling up
GLP-1: los medicamentos que estn redefiniendo salud, productividad y la economa global En Mxico, el contexto adquiere una dimensin particularmente crtica, ya que ms del 70% de la poblacin adulta vive con sobrepeso u obesidad, y las enfermedades metablicas representan una de las principales cargas econmicas del sistema de salud
El principal papel de la carnitina es acelerar el proceso de oxidacin de cidos grasos (y de disminucin de sustancial de la produccin de energa y al aumento de masa de tejido adiposo
One in three people in this country struggle to pay for prescription drugs
Simultaneously, oil red staining of liver showed that numerous lipid droplets accumulated in the hepatocytes of mouse at 1 day after operation, which decreased after 3 days and almost returned to normal after 7 days (Fig
Commercial strategy evolution The obesity market may no longer simply be about maximum weight loss. It may increasingly become about: long-term adherence affordability convenience lifecycle management chronic disease maintenance The broader obesity market is rapidly evolving from a single-product race into a full ecosystem of: induction therapies maintenance therapies oral options combination strategies AI-supported metabolic management The next battle may not just be: Who helps patients lose the most weight? But: Who helps patients sustain outcomes for years? The obesity therapeutics market is becoming far more sophisticated than many predicted